Forgot Password

Flat 25% discount on all reports exclusively for July & August 2018

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4071116
  • Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2016 | Report Code: HPH-4071116

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The global ortho biological products market is anticipated to grow to  with a CAGR of 7% between  2016-2023 . Global Orth biological product market  is growing as a result of significant growth in the medical devices industry especially owing to rise in aging population. Rising of ortho biological products is driven by growing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related process. 

As population continues to rise, there is immediate rise in aging population which is contributing towards the increasing orthobiological products industry as there is requirement of orthopedic procedures is higher in such elderly population. Many factors driving the growth of this market also include number of obese patients with increasing levels of osteoarthritis and rheumatoid arthritis and patients with demand for cartilage repair procedures. Also, there are rising occurrences of diseases like diabetes which is leading to slower bone and tissue healing, thus ensuing in rising numbers of trauma and sport related injuries. The market is facing specific restraint such as high cost associated with the products. These products have high costs, that are beyond the affordability of few people and it is restricting the growth of the market. The market has lots of potential opportunities with the increasing demand from emerging markets like china, Brazil, India, etc., increasing healthcare spending by people across geographies and rising medical tourism. The dearth of skilled professionals is major challenge which is faced by the market.

Source: OBRC Analysis

The segments of the ortho biological products market are on the basis of the applications, products, and end-user.

The products market segmentation includes:

  • Demineralized Bone Matrix
  • Machined Bones
  • Allograft
  • Bone Morphogenetic Protein
  • Stem Cell Therapy
  • Visco Supplementation
  • Other Applications








On the basis of applications, the market is segmented into:

  • Trauma
  • Spinal Fusion
  • Reconstructive Surgeries
  • Tendon & Ligament Repair
  • Other Applications






On the basis of end-user:

  • Hospitals
  • Orthopaedic clinics.



Visco supplementation holds the largest market share and is anticipated to maintain the current growth path during the coming period. Increasing popularity of visco supplementation over other products is due to their superior performance and benefits perceived by the patients. Visco supplements are witnessed to provide long lasting pain relief than other treatments. The fastest growing segment in products segment is anticipated to be of the stem cell therapy. The driving forces for this growth are projected to be advantages like reduction in cost of treatment, improved healing process, and fast recovery time.

Spinal fusion holds the major market share and is estimated to retain its position during the coming period. The factors helping the growth are rising aging population which requires the spinal fusion surgeries and the increasing prevalence of spinal injuries. Reconstructive surgeries are anticipated to show the rapid growth in the application segment because of technological innovations and growing popularity of cosmetic treatments.

The revenue for the above application and end-user segments are specific to the ortho biological products market. however, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product segment.

On the basis of geography, the global market of ortho biological products is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





The North America is the leading region of ortho biological products market. The market expansion and the lead is expected to sustain due to the increasing population base of geriatric patients, increasing prevalence of injuries, increasing medical device sales and growing number of orthopedic procedures. Another factor contributing to the major growth of the region is the rising prevalence of orthopedic disorders like rheumatoid arthritis and osteoporosis. Europe has the second highest share in the market and is anticipated to maintain its place over the coming period. Germany is projected to be the country to show highest growth in Europe owing to the presence of multiple healthcare companies, increasing awareness level of patients regarding ortho biological products and growing geriatric population base. Asia Pacific is expected to be the rapidly growing region with specific emphasis on South Korea, Malaysia, China, and India. The drivers for the profitable growth in the region are attributed to the rising disposal income of people, increasing expenditure power of the patients over healthcare, rising medical tourism to these nations, and growing awareness level of the patients. Technological innovations and government initiatives are expected to further increase the growth of the market in the region with presence of market growth oriented policies and strategies.

Major players of the ortho biological products business sector are:

  • Bioventus
  • Pioneer Surgical Technology
  • Baxter International Inc.
  • Smith and Nephew Plc
  • Sanofi
  • Tissue Banks Osiris Therapeutics Inc.
  • Berkeley Advanced Biomaterials Inc.
  • Stryker Corp









These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch to advance growth in the global ortho biological products market. Acquisition, product launches are the major strategies which are followed the by companies.

On November 2015, Bioventus acquired Bio Structures, to enlarge their surgical orthobiologics offering. Bioventus, is a worldwide leader in ortho biologic solutions has announced that it has acquired BioStructures LLC. The agreement includes the whole portfolio of product and its research and development channels.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in ortho biological products market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023.
  • Report includes detailed analysis of different segments such as on the basis of the applications, products, and region.
  • Identify and understand the strength, opportunities, challenges and threat of the ortho biological products market.
  • Covers detailed analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, competitive landscape analysis of major players of ortho biological products market.
  • Detailed analysis of various the regulatory policies which are affecting the global ortho biological products market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global ortho biological products market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the ortho biological products market, with giving extensive SCOT analysis of key companies. 

Key findings of the global ortho biological products market:

  • Immediate rise in aging population and rising awareness among patient & athletes are  contributing towards the increasing orthobiologics  products industry as these orthobiologics substances are used for faster healing process .
  • Visco supplementation holds the largest market share and is anticipated to maintain the current growth path during the coming period.
  • The North America is the leading region of ortho biological products market.
  • Acquisition, product launches are the major strategies which are followed by companies in the ortho biological products market.

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. MARKET METHODOLOGY

 

 2. MARKET OVERVIEW

2.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

 

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES AND ANALYSIS

2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

 

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. GROWING GERIATRIC POPULATION

3.1.2. INCREASING AWARENESS REGARDING ACCEPTANCE OF ORTHOBIOLOGICS

3.1.3. INCREASING DISPOSABLE INCOME

3.1.4. INCREASING NUMBER OF ORTHOPAEDIC RELATED PROCEDURES

3.1.5. BENEFITS ASSOCIATED SUCH AS REDUCED PAIN AND FASTER HEALING AND RECOVERY

3.1.6. TECHNOLOGICAL ADVANCEMENTS

3.2. MARKET RESTRAINTS

3.2.1. HIGH COST ASSOCIATED WITH THE PRODUCTS.

3.2.2. LACK OF AWARENESS

3.3. MARKET OPPORTUNITIES

3.3.1. RISING DEMAND FROM EMERGING MARKETS

3.3.2. RISING HEALTHCARE SPENDING BY PEOPLE ACROSS GEOGRAPHY

3.3.3. GROWING MEDICAL TOURISM

3.4.   MARKET CHALLENGES

3.4.1. DEARTH OF TRAINED PERSONNEL

3.4.2. TECHNOLOGICAL COMPLEXITY

 

4.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION

4.1.         MARKET DEFINITION AND SCOPE

4.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.         OPPORTUNITY MATRIX

4.5.         MARKET SEGMENTATION

4.1.1 GLOBAL RECONSTRUCTIVE SURGERIES BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.2 GLOBAL TRAUMA BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.3  GLOBAL SPINAL FUSION BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.4 GLOBAL TENDON & LIGAMENT REPAIR BY APPLICATION MARKET

4.1.4.1   ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.4.3. KEY PLAYERS & KEY PRODUCTS

4.5.4.4. KEY CONCLUSIONS

 4.1.5 OTHER APPLICATIONS

4.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.5.3. KEY PLAYERS & KEY PRODUCTS

4.5.5.4. KEY CONCLUSIONS

5.1 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT

5.1.         MARKET DEFINITION AND SCOPE

5.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.         OPPORTUNITY MATRIX

5.5.         MARKET SEGMENTATION

5.1.1 GLOBAL DBM MARKET 

5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3. KEY PLAYERS & KEY PRODUCTS

5.5.1.4. KEY CONCLUSIONS

5.1.2 GLOBAL ALLOGRAFT MARKET

5.1.2.1         ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3. KEY PLAYERS & KEY PRODUCTS

5.5.2.4. KEY CONCLUSIONS

5.1.3   GLOBAL BMP MARKET

5.1.3.1                ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3. KEY PLAYERS & KEY PRODUCTS

5.5.3.4. KEY CONCLUSIONS

5.1.4  GLOBAL VISCOSUPPLEMENTATION MARKET

  5.1.4.1   ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.4.3. KEY PLAYERS & KEY PRODUCTS

5.5.4.4. KEY CONCLUSIONS

5.1.5 GLOBAL MACHINED BONES MARKET

 5.1.5.1 ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3. KEY PLAYERS & KEY PRODUCTS

5.5.5.4. KEY CONCLUSIONS

5.1.6 GLOBAL STEM CELL THERAPY MARKET

5.1.6.1 ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3. KEY PLAYERS & KEY PRODUCTS

5.5.5.4. KEY CONCLUSIONS

 5.1.6         GLOBAL OTHERS MARKET

5.1.6.1         ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.6.3. KEY PLAYERS & KEY PRODUCTS

5.5.6.4. KEY CONCLUSIONS

 

 6 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER

6.1.         MARKET DEFINITION AND SCOPE

6.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.         OPPORTUNITY MATRIX

6.5.         MARKET SEGMENTATION

6.5.1           GLOBAL HOSPITALS MARKET

6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3. KEY PLAYERS & KEY PRODUCTS

6.5.1.4. KEY CONCLUSIONS

6.5.2      GLOBAL ORTHOPEDIC CLINICS MARKET

6.5.2.1 GLOBAL HOSPITALS MARKET

6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3. KEY PLAYERS & KEY PRODUCTS

6.5.2.4. KEY CONCLUSIONS

8.            COMPETITIVE LANDSCAPE

8.1.         KEY STRATEGIES

8.1.1.     LIST OF MERGERS AND ACQUISITION

8.1.2.     LIST OF JOINT VENTURES

8.1.3.     LIST OF PRODUCT LAUNCHES

8.1.4.     LIST OF PARTNERSHIPS

9.            GEOGRAPHIC ANALYSIS

9.1.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

9.2.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

9.3.         OPPORTUNITY MATRIX

9.4.         GLOBAL FINTECH BLOCKCHAIN MARKET BY REGION 2015-2024 

9.4.1.     NORTH AMERICA

9.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.1.2. TOP COUNTRY ANALYSIS

9.4.1.2.1.              U.S.

9.4.1.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.1.3.          KEY CONCLUSIONS

9.4.1.2.2.              CANADA

9.4.1.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.2.3.          KEY CONCLUSIONS

9.4.2.     EUROPE

9.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.2.2. TOP COUNTRY ANALYSIS

9.4.2.2.1.              UK

9.4.2.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.1.3.          KEY CONCLUSIONS

9.4.2.2.2.              FRANCE

9.4.2.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.2.3.          KEY CONCLUSIONS

9.4.2.2.3.              GERMANY

9.4.2.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.3.3.          KEY CONCLUSIONS

9.4.2.2.4.              SPAIN

9.4.2.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.4.3.          KEY CONCLUSIONS

9.4.2.2.5.              REST OF EUROPE

9.4.2.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.5.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.2.2.5.3.          KEY CONCLUSIONS

9.4.3.     ASIA PACIFIC

9.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.3.2. TOP COUNTRY ANALYSIS

9.4.3.2.1.              CHINA

9.4.3.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.1.3.          KEY CONCLUSIONS

9.4.3.2.2.              INDIA

9.4.3.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.2.3.          KEY CONCLUSIONS

9.4.3.2.3.              JAPAN

9.4.3.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.3.3.          KEY CONCLUSIONS

9.4.3.2.4.              AUSTRALIA

9.4.3.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.4.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.3.2.4.3.          KEY CONCLUSIONS

9.4.3.2.5.              REST OF ASIA PACIFIC

9.4.3.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.5.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.3.2.5.3.          KEY CONCLUSIONS

9.4.4.     ROW

9.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.4.2. TOP COUNTRY ANALYSIS

9.4.4.2.1.              LATIN AMERICA

9.4.4.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.1.3.          KEY CONCLUSIONS

9.4.4.2.2.              MIDDLE EAST & AFRICA

9.4.4.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.2.3.          KEY CONCLUSIONS

 

10 COMPANY PROFILE

 

10.1 BERKELEY ADVANCED BIOMATERIALS, INC.

10.2.1.   OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.2 BAXTER INTERNATIONAL, INC

10.2.1         OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

 10.3 BIOVENTUS

10.2.1  OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.4  BONE BIOLOGICS, INC.

10.2.1 OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.5 DEPUY SYNTHES, INC

10.5.1 OVERVIEW

10.5.2.   PRODUCT PORTFOLIO

10.5.3.   STRATEGIC INITIATIVES

10.5.4.   SCOT ANALYSIS

10.5.5.   STRATEGIC ANALYSIS

10.6 INTEGRA LIFESCIENCES CORP

10.6.1 OVERVIEW

10.6.2.   PRODUCT PORTFOLIO

10.6.3.   STRATEGIC INITIATIVES

10.6.4.   SCOT ANALYSIS

10.6.5.   STRATEGIC ANALYSIS

10.7  INTERVENTIONAL SPINE, INC

10.7.1 OVERVIEW

10.7.2.   PRODUCT PORTFOLIO

10.7.3.   STRATEGIC INITIATIVES

10.7.4.   SCOT ANALYSIS

10.7.5.   STRATEGIC ANALYSIS

10.8 MEDTRONIC, INC.

10.8.1 OVERVIEW

10.8.2.   PRODUCT PORTFOLIO

10.8.3.   STRATEGIC INITIATIVES

10.8.4.   SCOT ANALYSIS

10.8.5.   STRATEGIC ANALYSIS

10.9  OSIRIS THERAPEUTICS, INC.

10.9.1  OVERVIEW

10.8.2.   PRODUCT PORTFOLIO

10.8.3.   STRATEGIC INITIATIVES

10.8.4.   SCOT ANALYSIS

10.8.5.   STRATEGIC ANALYSIS

10.10  PIONEER SURGICAL TECHNOLOGY

10.10.1 OVERVIEW

10.10.2.PRODUCT PORTFOLIO

10.10.3.STRATEGIC INITIATIVES

10.10.4.SCOT ANALYSIS

10.10.5.STRATEGIC ANALYSIS

10.11 SANOFI

10.11.1 OVERVIEW

10.11.2.PRODUCT PORTFOLIO

10.11.3.STRATEGIC INITIATIVES

10.11.4.SCOT ANALYSIS

10.11.5.STRATEGIC ANALYSIS

10.12 SMITH AND NEPHEW PLC

10.12.11OVERVIEW

10.12.2.PRODUCT PORTFOLIO

10.12.3.STRATEGIC INITIATIVES

10.12.4.SCOT ANALYSIS

10.12.5.STRATEGIC ANALYSIS

10.13 STRYKER CORP.

10.12.11OVERVIEW

10.12.2.PRODUCT PORTFOLIO

10.12.3.STRATEGIC INITIATIVES

10.12.4.SCOT ANALYSIS

10.12.5.STRATEGIC ANALYSIS

10.14 TISSUE BANKS INTERNATIONAL

10.14.1OVERVIEW

10.14.2.PRODUCT PORTFOLIO

10.14.3.STRATEGIC INITIATIVES

10.14.4.SCOT ANALYSIS

10.14.5.STRATEGIC ANALYSIS

10.15 TISSUE GENESIS, INC.

10.15.1 OVERVIEW

10.15.2.PRODUCT PORTFOLIO

10.15.3.STRATEGIC INITIATIVES

10.15.4.SCOT ANALYSIS

10.15.5.STRATEGIC ANALYSIS

 

LIST OF TABLE

1.GLOBAL GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

2.GLOBAL RECONSTRUCTIVE SURGERIES APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3 GLOBAL  TRAUMA APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4 GLOBAL TRAUMA APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5 GLOBAL GLOBAL SPINAL FUSION APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6 GLOBAL TENDON & LIGAMENT REPAIR APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7 GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT 2015-2024 ($ MILLION)

9 GLOBAL DBM PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10  GLOBAL ALLOGRAFT PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11 GLOBAL BMP  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12 GLOBAL VISCOSUPPLEMENTATION PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13 GLOBALMACHINED BONES PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15 GLOBAL STEM CELL THERAPY  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16 GLOBAL OTHERS MARKET  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

17 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

18 GLOBAL   HOSPITALS ENDUSER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19 GLOBAL  ORTHOPEDIC CLINICS ENDUSER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20 NORTH AMERICA ORTHO BIOLOGICAL PRODUCTS  Market BY APPLICATION   2015-2024 ($ MILLION)

21.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

22. ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

23 NORTH AMERICA  ORTHO BIOLOGICAL PRODUCTS  MARKET BY APPLICATION 2015-2024 ($ MILLION)

25.EUROPE  ORTHO BIOLOGICAL PRODUCTS  MARKET BY APPLICATION 2015-2024 ($ MILLION)

26.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.REST OF THE WORLD  ORTHO BIOLOGICAL PRODUCTS  BY APPLICATION 2015-2024 ($ MILLION)

28 NORTH ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

29.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

30.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

31.REST OF THE WORLD ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

32 NORTH ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

33.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

34.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

35.REST OF THE WORLD ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

36 NORTH NORTH  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER 2015-2024 ($ MILLION)

33.EUROPE NORTH  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

34.ASIA PACIFIC  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

35.REST OF THE WORLD  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION) 2015-2024 ($ MILLION)

36 UNITED STATES ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

41.UNITED STATES ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

42 UNITED STATES  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

43 CANADA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

44 CANADA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

45 CANADA ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

46 U.K ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

47 U.K ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

48 U.K ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

49 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

50 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

51 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

52 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION

53 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

54 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

55 SPAIN ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

56 SPAIN ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

57 SPAIN  ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

58 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

59 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

60 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

61 CHINA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

62 CHINA  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

63 CHINA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

64 INDIA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

65 INDIA  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

66 INDIA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

67 JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

68  JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

69 JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

70 AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

71  AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

72 AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

73 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

74 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

75 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

76 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

77 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

78 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

79 MENA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

80 MENA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

81 MENA AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

 

LIST OF FIGURE

1 GLOBAL RECONSTRUCTIVE SURGERIES MARKET  2015-2024 ($ MILLION)

2 GLOBAL  TRAUMA MARKET  2015-2024 ($ MILLION)

3 GLOBAL SPINAL FUSIONL  MARKET  2015-2024 ($ MILLION)

4 GLOBAL TENDON & LIGAMENT REPAIR MARKET  2015-2024 ($ MILLION)

5 GLOBAL  OTHER APPLICATIONS MARKET  2015-2024 ($ MILLION)

6 GLOBAL  DBM MARKET 2015-2024 ($ MILLION)

7 GLOBAL ALLOGRAFT MARKET 2015-2024 ($ MILLION)

8 GLOBAL BMP MARKET 2015-2024 ($ MILLION)

9 GLOBAL VISCOSUPPLEMENTATION MARKET 2015-2024 ($ MILLION)

10 GLOBALMACHINED BONES MARKET 2015-2024 ($ MILLION)

11 GLOBAL STEM CELL THERAPY MARKET 2015-2024 ($ MILLION)

12 GLOBAL OTHERS MARKET 2015-2024 ($ MILLION)

13 GLOBAL   HOSPITALS MARKET  2015-2024 ($ MILLION)

14 GLOBAL  ORTHOPEDIC CLINICS  MARKET  2015-2024 ($ MILLION)

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4071116
  • Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2016 | Report Code: HPH-4071116

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The global ortho biological products market is anticipated to grow to  with a CAGR of 7% between  2016-2023 . Global Orth biological product market  is growing as a result of significant growth in the medical devices industry especially owing to rise in aging population. Rising of ortho biological products is driven by growing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related process. 

As population continues to rise, there is immediate rise in aging population which is contributing towards the increasing orthobiological products industry as there is requirement of orthopedic procedures is higher in such elderly population. Many factors driving the growth of this market also include number of obese patients with increasing levels of osteoarthritis and rheumatoid arthritis and patients with demand for cartilage repair procedures. Also, there are rising occurrences of diseases like diabetes which is leading to slower bone and tissue healing, thus ensuing in rising numbers of trauma and sport related injuries. The market is facing specific restraint such as high cost associated with the products. These products have high costs, that are beyond the affordability of few people and it is restricting the growth of the market. The market has lots of potential opportunities with the increasing demand from emerging markets like china, Brazil, India, etc., increasing healthcare spending by people across geographies and rising medical tourism. The dearth of skilled professionals is major challenge which is faced by the market.

Source: OBRC Analysis

The segments of the ortho biological products market are on the basis of the applications, products, and end-user.

The products market segmentation includes:

  • Demineralized Bone Matrix
  • Machined Bones
  • Allograft
  • Bone Morphogenetic Protein
  • Stem Cell Therapy
  • Visco Supplementation
  • Other Applications








On the basis of applications, the market is segmented into:

  • Trauma
  • Spinal Fusion
  • Reconstructive Surgeries
  • Tendon & Ligament Repair
  • Other Applications






On the basis of end-user:

  • Hospitals
  • Orthopaedic clinics.



Visco supplementation holds the largest market share and is anticipated to maintain the current growth path during the coming period. Increasing popularity of visco supplementation over other products is due to their superior performance and benefits perceived by the patients. Visco supplements are witnessed to provide long lasting pain relief than other treatments. The fastest growing segment in products segment is anticipated to be of the stem cell therapy. The driving forces for this growth are projected to be advantages like reduction in cost of treatment, improved healing process, and fast recovery time.

Spinal fusion holds the major market share and is estimated to retain its position during the coming period. The factors helping the growth are rising aging population which requires the spinal fusion surgeries and the increasing prevalence of spinal injuries. Reconstructive surgeries are anticipated to show the rapid growth in the application segment because of technological innovations and growing popularity of cosmetic treatments.

The revenue for the above application and end-user segments are specific to the ortho biological products market. however, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product segment.

On the basis of geography, the global market of ortho biological products is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





The North America is the leading region of ortho biological products market. The market expansion and the lead is expected to sustain due to the increasing population base of geriatric patients, increasing prevalence of injuries, increasing medical device sales and growing number of orthopedic procedures. Another factor contributing to the major growth of the region is the rising prevalence of orthopedic disorders like rheumatoid arthritis and osteoporosis. Europe has the second highest share in the market and is anticipated to maintain its place over the coming period. Germany is projected to be the country to show highest growth in Europe owing to the presence of multiple healthcare companies, increasing awareness level of patients regarding ortho biological products and growing geriatric population base. Asia Pacific is expected to be the rapidly growing region with specific emphasis on South Korea, Malaysia, China, and India. The drivers for the profitable growth in the region are attributed to the rising disposal income of people, increasing expenditure power of the patients over healthcare, rising medical tourism to these nations, and growing awareness level of the patients. Technological innovations and government initiatives are expected to further increase the growth of the market in the region with presence of market growth oriented policies and strategies.

Major players of the ortho biological products business sector are:

  • Bioventus
  • Pioneer Surgical Technology
  • Baxter International Inc.
  • Smith and Nephew Plc
  • Sanofi
  • Tissue Banks Osiris Therapeutics Inc.
  • Berkeley Advanced Biomaterials Inc.
  • Stryker Corp









These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch to advance growth in the global ortho biological products market. Acquisition, product launches are the major strategies which are followed the by companies.

On November 2015, Bioventus acquired Bio Structures, to enlarge their surgical orthobiologics offering. Bioventus, is a worldwide leader in ortho biologic solutions has announced that it has acquired BioStructures LLC. The agreement includes the whole portfolio of product and its research and development channels.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in ortho biological products market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023.
  • Report includes detailed analysis of different segments such as on the basis of the applications, products, and region.
  • Identify and understand the strength, opportunities, challenges and threat of the ortho biological products market.
  • Covers detailed analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, competitive landscape analysis of major players of ortho biological products market.
  • Detailed analysis of various the regulatory policies which are affecting the global ortho biological products market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global ortho biological products market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the ortho biological products market, with giving extensive SCOT analysis of key companies. 

Key findings of the global ortho biological products market:

  • Immediate rise in aging population and rising awareness among patient & athletes are  contributing towards the increasing orthobiologics  products industry as these orthobiologics substances are used for faster healing process .
  • Visco supplementation holds the largest market share and is anticipated to maintain the current growth path during the coming period.
  • The North America is the leading region of ortho biological products market.
  • Acquisition, product launches are the major strategies which are followed by companies in the ortho biological products market.

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. MARKET METHODOLOGY

 

 2. MARKET OVERVIEW

2.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

 

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES AND ANALYSIS

2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

 

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. GROWING GERIATRIC POPULATION

3.1.2. INCREASING AWARENESS REGARDING ACCEPTANCE OF ORTHOBIOLOGICS

3.1.3. INCREASING DISPOSABLE INCOME

3.1.4. INCREASING NUMBER OF ORTHOPAEDIC RELATED PROCEDURES

3.1.5. BENEFITS ASSOCIATED SUCH AS REDUCED PAIN AND FASTER HEALING AND RECOVERY

3.1.6. TECHNOLOGICAL ADVANCEMENTS

3.2. MARKET RESTRAINTS

3.2.1. HIGH COST ASSOCIATED WITH THE PRODUCTS.

3.2.2. LACK OF AWARENESS

3.3. MARKET OPPORTUNITIES

3.3.1. RISING DEMAND FROM EMERGING MARKETS

3.3.2. RISING HEALTHCARE SPENDING BY PEOPLE ACROSS GEOGRAPHY

3.3.3. GROWING MEDICAL TOURISM

3.4.   MARKET CHALLENGES

3.4.1. DEARTH OF TRAINED PERSONNEL

3.4.2. TECHNOLOGICAL COMPLEXITY

 

4.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION

4.1.         MARKET DEFINITION AND SCOPE

4.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.         OPPORTUNITY MATRIX

4.5.         MARKET SEGMENTATION

4.1.1 GLOBAL RECONSTRUCTIVE SURGERIES BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.2 GLOBAL TRAUMA BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.3  GLOBAL SPINAL FUSION BY APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.4 GLOBAL TENDON & LIGAMENT REPAIR BY APPLICATION MARKET

4.1.4.1   ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.4.3. KEY PLAYERS & KEY PRODUCTS

4.5.4.4. KEY CONCLUSIONS

 4.1.5 OTHER APPLICATIONS

4.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.5.3. KEY PLAYERS & KEY PRODUCTS

4.5.5.4. KEY CONCLUSIONS

5.1 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT

5.1.         MARKET DEFINITION AND SCOPE

5.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.         OPPORTUNITY MATRIX

5.5.         MARKET SEGMENTATION

5.1.1 GLOBAL DBM MARKET 

5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3. KEY PLAYERS & KEY PRODUCTS

5.5.1.4. KEY CONCLUSIONS

5.1.2 GLOBAL ALLOGRAFT MARKET

5.1.2.1         ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3. KEY PLAYERS & KEY PRODUCTS

5.5.2.4. KEY CONCLUSIONS

5.1.3   GLOBAL BMP MARKET

5.1.3.1                ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3. KEY PLAYERS & KEY PRODUCTS

5.5.3.4. KEY CONCLUSIONS

5.1.4  GLOBAL VISCOSUPPLEMENTATION MARKET

  5.1.4.1   ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.4.3. KEY PLAYERS & KEY PRODUCTS

5.5.4.4. KEY CONCLUSIONS

5.1.5 GLOBAL MACHINED BONES MARKET

 5.1.5.1 ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3. KEY PLAYERS & KEY PRODUCTS

5.5.5.4. KEY CONCLUSIONS

5.1.6 GLOBAL STEM CELL THERAPY MARKET

5.1.6.1 ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3. KEY PLAYERS & KEY PRODUCTS

5.5.5.4. KEY CONCLUSIONS

 5.1.6         GLOBAL OTHERS MARKET

5.1.6.1         ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.6.3. KEY PLAYERS & KEY PRODUCTS

5.5.6.4. KEY CONCLUSIONS

 

 6 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER

6.1.         MARKET DEFINITION AND SCOPE

6.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.         OPPORTUNITY MATRIX

6.5.         MARKET SEGMENTATION

6.5.1           GLOBAL HOSPITALS MARKET

6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3. KEY PLAYERS & KEY PRODUCTS

6.5.1.4. KEY CONCLUSIONS

6.5.2      GLOBAL ORTHOPEDIC CLINICS MARKET

6.5.2.1 GLOBAL HOSPITALS MARKET

6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3. KEY PLAYERS & KEY PRODUCTS

6.5.2.4. KEY CONCLUSIONS

8.            COMPETITIVE LANDSCAPE

8.1.         KEY STRATEGIES

8.1.1.     LIST OF MERGERS AND ACQUISITION

8.1.2.     LIST OF JOINT VENTURES

8.1.3.     LIST OF PRODUCT LAUNCHES

8.1.4.     LIST OF PARTNERSHIPS

9.            GEOGRAPHIC ANALYSIS

9.1.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

9.2.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

9.3.         OPPORTUNITY MATRIX

9.4.         GLOBAL FINTECH BLOCKCHAIN MARKET BY REGION 2015-2024 

9.4.1.     NORTH AMERICA

9.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.1.2. TOP COUNTRY ANALYSIS

9.4.1.2.1.              U.S.

9.4.1.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.1.3.          KEY CONCLUSIONS

9.4.1.2.2.              CANADA

9.4.1.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.2.3.          KEY CONCLUSIONS

9.4.2.     EUROPE

9.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.2.2. TOP COUNTRY ANALYSIS

9.4.2.2.1.              UK

9.4.2.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.1.3.          KEY CONCLUSIONS

9.4.2.2.2.              FRANCE

9.4.2.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.2.3.          KEY CONCLUSIONS

9.4.2.2.3.              GERMANY

9.4.2.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.3.3.          KEY CONCLUSIONS

9.4.2.2.4.              SPAIN

9.4.2.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.4.3.          KEY CONCLUSIONS

9.4.2.2.5.              REST OF EUROPE

9.4.2.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.5.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.2.2.5.3.          KEY CONCLUSIONS

9.4.3.     ASIA PACIFIC

9.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.3.2. TOP COUNTRY ANALYSIS

9.4.3.2.1.              CHINA

9.4.3.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.1.3.          KEY CONCLUSIONS

9.4.3.2.2.              INDIA

9.4.3.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.2.3.          KEY CONCLUSIONS

9.4.3.2.3.              JAPAN

9.4.3.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.3.3.          KEY CONCLUSIONS

9.4.3.2.4.              AUSTRALIA

9.4.3.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.4.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.3.2.4.3.          KEY CONCLUSIONS

9.4.3.2.5.              REST OF ASIA PACIFIC

9.4.3.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.5.2.          KEY  PLAYERS & KEY PRODUCTS

9.4.3.2.5.3.          KEY CONCLUSIONS

9.4.4.     ROW

9.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.4.2. TOP COUNTRY ANALYSIS

9.4.4.2.1.              LATIN AMERICA

9.4.4.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.1.3.          KEY CONCLUSIONS

9.4.4.2.2.              MIDDLE EAST & AFRICA

9.4.4.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.2.3.          KEY CONCLUSIONS

 

10 COMPANY PROFILE

 

10.1 BERKELEY ADVANCED BIOMATERIALS, INC.

10.2.1.   OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.2 BAXTER INTERNATIONAL, INC

10.2.1         OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

 10.3 BIOVENTUS

10.2.1  OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.4  BONE BIOLOGICS, INC.

10.2.1 OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.5 DEPUY SYNTHES, INC

10.5.1 OVERVIEW

10.5.2.   PRODUCT PORTFOLIO

10.5.3.   STRATEGIC INITIATIVES

10.5.4.   SCOT ANALYSIS

10.5.5.   STRATEGIC ANALYSIS

10.6 INTEGRA LIFESCIENCES CORP

10.6.1 OVERVIEW

10.6.2.   PRODUCT PORTFOLIO

10.6.3.   STRATEGIC INITIATIVES

10.6.4.   SCOT ANALYSIS

10.6.5.   STRATEGIC ANALYSIS

10.7  INTERVENTIONAL SPINE, INC

10.7.1 OVERVIEW

10.7.2.   PRODUCT PORTFOLIO

10.7.3.   STRATEGIC INITIATIVES

10.7.4.   SCOT ANALYSIS

10.7.5.   STRATEGIC ANALYSIS

10.8 MEDTRONIC, INC.

10.8.1 OVERVIEW

10.8.2.   PRODUCT PORTFOLIO

10.8.3.   STRATEGIC INITIATIVES

10.8.4.   SCOT ANALYSIS

10.8.5.   STRATEGIC ANALYSIS

10.9  OSIRIS THERAPEUTICS, INC.

10.9.1  OVERVIEW

10.8.2.   PRODUCT PORTFOLIO

10.8.3.   STRATEGIC INITIATIVES

10.8.4.   SCOT ANALYSIS

10.8.5.   STRATEGIC ANALYSIS

10.10  PIONEER SURGICAL TECHNOLOGY

10.10.1 OVERVIEW

10.10.2.PRODUCT PORTFOLIO

10.10.3.STRATEGIC INITIATIVES

10.10.4.SCOT ANALYSIS

10.10.5.STRATEGIC ANALYSIS

10.11 SANOFI

10.11.1 OVERVIEW

10.11.2.PRODUCT PORTFOLIO

10.11.3.STRATEGIC INITIATIVES

10.11.4.SCOT ANALYSIS

10.11.5.STRATEGIC ANALYSIS

10.12 SMITH AND NEPHEW PLC

10.12.11OVERVIEW

10.12.2.PRODUCT PORTFOLIO

10.12.3.STRATEGIC INITIATIVES

10.12.4.SCOT ANALYSIS

10.12.5.STRATEGIC ANALYSIS

10.13 STRYKER CORP.

10.12.11OVERVIEW

10.12.2.PRODUCT PORTFOLIO

10.12.3.STRATEGIC INITIATIVES

10.12.4.SCOT ANALYSIS

10.12.5.STRATEGIC ANALYSIS

10.14 TISSUE BANKS INTERNATIONAL

10.14.1OVERVIEW

10.14.2.PRODUCT PORTFOLIO

10.14.3.STRATEGIC INITIATIVES

10.14.4.SCOT ANALYSIS

10.14.5.STRATEGIC ANALYSIS

10.15 TISSUE GENESIS, INC.

10.15.1 OVERVIEW

10.15.2.PRODUCT PORTFOLIO

10.15.3.STRATEGIC INITIATIVES

10.15.4.SCOT ANALYSIS

10.15.5.STRATEGIC ANALYSIS

 

LIST OF TABLE

1.GLOBAL GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

2.GLOBAL RECONSTRUCTIVE SURGERIES APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3 GLOBAL  TRAUMA APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4 GLOBAL TRAUMA APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5 GLOBAL GLOBAL SPINAL FUSION APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6 GLOBAL TENDON & LIGAMENT REPAIR APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7 GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT 2015-2024 ($ MILLION)

9 GLOBAL DBM PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10  GLOBAL ALLOGRAFT PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11 GLOBAL BMP  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12 GLOBAL VISCOSUPPLEMENTATION PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13 GLOBALMACHINED BONES PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15 GLOBAL STEM CELL THERAPY  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16 GLOBAL OTHERS MARKET  PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

17 GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

18 GLOBAL   HOSPITALS ENDUSER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19 GLOBAL  ORTHOPEDIC CLINICS ENDUSER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20 NORTH AMERICA ORTHO BIOLOGICAL PRODUCTS  Market BY APPLICATION   2015-2024 ($ MILLION)

21.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

22. ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

23 NORTH AMERICA  ORTHO BIOLOGICAL PRODUCTS  MARKET BY APPLICATION 2015-2024 ($ MILLION)

25.EUROPE  ORTHO BIOLOGICAL PRODUCTS  MARKET BY APPLICATION 2015-2024 ($ MILLION)

26.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.REST OF THE WORLD  ORTHO BIOLOGICAL PRODUCTS  BY APPLICATION 2015-2024 ($ MILLION)

28 NORTH ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

29.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

30.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

31.REST OF THE WORLD ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

32 NORTH ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

33.EUROPE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

34.ASIA PACIFIC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

35.REST OF THE WORLD ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

36 NORTH NORTH  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER 2015-2024 ($ MILLION)

33.EUROPE NORTH  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

34.ASIA PACIFIC  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION)

35.REST OF THE WORLD  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER  2015-2024 ($ MILLION) 2015-2024 ($ MILLION)

36 UNITED STATES ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION 2015-2024 ($ MILLION)

41.UNITED STATES ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

42 UNITED STATES  ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

43 CANADA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

44 CANADA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

45 CANADA ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

46 U.K ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

47 U.K ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

48 U.K ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

49 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

50 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

51 FRANCE ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

52 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION

53 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

54 GERMANY ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

55 SPAIN ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

56 SPAIN ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

57 SPAIN  ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

58 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

59 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

60 ROE  ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

61 CHINA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

62 CHINA  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

63 CHINA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

64 INDIA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

65 INDIA  ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

66 INDIA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

67 JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

68  JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

69 JAPAN ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

70 AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

71  AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

72 AUSTRALIA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

73 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

74 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

75 ROAPAC ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

76 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

77 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

78 LATIN AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

79 MENA ORTHO BIOLOGICAL PRODUCTS MARKET BY APPLICATION  2015-2024 ($ MILLION)

80 MENA ORTHO BIOLOGICAL PRODUCTS MARKET BY PRODUCT  2015-2024 ($ MILLION)

81 MENA AMERICA ORTHO BIOLOGICAL PRODUCTS MARKET BY END-USER   2015-2024 ($ MILLION)

 

LIST OF FIGURE

1 GLOBAL RECONSTRUCTIVE SURGERIES MARKET  2015-2024 ($ MILLION)

2 GLOBAL  TRAUMA MARKET  2015-2024 ($ MILLION)

3 GLOBAL SPINAL FUSIONL  MARKET  2015-2024 ($ MILLION)

4 GLOBAL TENDON & LIGAMENT REPAIR MARKET  2015-2024 ($ MILLION)

5 GLOBAL  OTHER APPLICATIONS MARKET  2015-2024 ($ MILLION)

6 GLOBAL  DBM MARKET 2015-2024 ($ MILLION)

7 GLOBAL ALLOGRAFT MARKET 2015-2024 ($ MILLION)

8 GLOBAL BMP MARKET 2015-2024 ($ MILLION)

9 GLOBAL VISCOSUPPLEMENTATION MARKET 2015-2024 ($ MILLION)

10 GLOBALMACHINED BONES MARKET 2015-2024 ($ MILLION)

11 GLOBAL STEM CELL THERAPY MARKET 2015-2024 ($ MILLION)

12 GLOBAL OTHERS MARKET 2015-2024 ($ MILLION)

13 GLOBAL   HOSPITALS MARKET  2015-2024 ($ MILLION)

14 GLOBAL  ORTHOPEDIC CLINICS  MARKET  2015-2024 ($ MILLION)

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion